Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2021

Rhea-AI Summary

Seer Inc. (NASDAQ: SEER) will release its financial results for Q4 and full year 2021 on February 28, 2022, after market close. A conference call with management will follow at 1:30 PM PT / 4:30 PM ET, available via a live webcast on Seer's investor website. Seer specializes in proteomics, offering the Proteograph Product Suite, which comprises engineered nanoparticles and software for comprehensive proteomic analysis. The suite aims to enhance research efficiency, though it is not intended for diagnostic use.

Positive

• Upcoming financial results announcement on February 28, 2022.
• Management conference call to discuss results.
• Seer's Proteograph Product Suite provides deep proteomic analysis quickly.

Negative

• None.

REDWOOD CITY, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the fourth quarter and full year 2021 after market close on Monday, February 28, 2022. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.

About Seer

Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph™ Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor Contact
Carrie Mendivil
investor@seer.bio

Media Contact
Karen Possemato
pr@seer.bio

FAQ

When will Seer Inc. report its financial results?

Seer Inc. will report its financial results for Q4 and full year 2021 on February 28, 2022.

What time is Seer Inc.'s conference call?

The conference call will start at 1:30 PM PT / 4:30 PM ET on February 28, 2022.

Where can I listen to Seer Inc.'s financial results webcast?

The live webcast will be available on the Investor section of Seer's website at investor.seer.bio.

What products does Seer Inc. offer?

Seer Inc. offers the Proteograph Product Suite for deep, unbiased proteomic analysis.